CIA
ALDX icon

Caerus Investment Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

Caerus Investment Advisors’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.4K Buy
+11,455
New +$50.2K 0.01% 274

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Caerus Investment Advisors's ALDX Position: Q1 2026 in Review

Caerus Investment Advisors opened a new position in Aldeyra Therapeutics (ALDX) in Q1 2026: 11,455 shares worth $19.4K. The stake represents 0.01% of the portfolio and ranks #274 among its holdings.

126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • Caerus Investment Advisors held 11,455 shares of Aldeyra Therapeutics worth $19.4K as of Q1 2026.
  • Aldeyra Therapeutics was a new Caerus Investment Advisors position in Q1 2026.
  • Aldeyra Therapeutics made up 0.01% of Caerus Investment Advisors's portfolio in Q1 2026, its #274 holding.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on Caerus Investment Advisors's 13F filing for Q1 2026, filed 1 Jun 2026.